Together, these data indicate that the tyrosine phosphatase activity of CD45 is crucial for enhancing Wnt/β-catenin signaling, which is responsible for stemness and therapy resistance in CRC cells. The gene discussed is PTPRC; the disease is colorectal carcinoma.